AmpliSeq for Illumina sequencing solution

Wednesday, 07 February, 2018 | Supplied by: Illumina Australia Pty Ltd


Thermo Fisher Scientific has partnered with Illumina to make the former’s suite of AmpliSeq chemistry products compatible with the latter’s next-generation sequencing (NGS) platforms. The end result, AmpliSeq for Illumina, enables fast, robust, targeted library prep for all Illumina sequencers.

The solution offers a highly multiplexed polymerase chain reaction (PCR)-based workflow for use with targets ranging from a few to hundreds in a single run. Users can prepare DNA or RNA libraries from as little as 1 ng input in just 5 h, with a comprehensive menu of panels and a wide variety of sample types.

Panels are optimised for clinical cancer and genetic disease research applications, and are available as ready-to-use, community or custom panels. AmpliSeq panels can accommodate high-quality samples such as blood, cell culture or fresh frozen tissue, and also challenging samples such as formalin-fixed paraffin-embedded (FFPE) tissue. Users can select from predesigned panels or customise their content for a variety of genomes and flexibility.

AmpliSeq for Illumina sequencing offers high-confidence data to researchers in a wide variety of application areas. The complete workflow, from design to analysis, is supported by Illumina.

Online: www.illumina.com
Phone: 03 9212 9900
Related Products

Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium

The products provide researchers and manufacturers with high-performance, scalable and...

Grace Bio-Labs protein microarray tools

Grace Bio-Labs' microarray substrates provide high binding capacity and enable high assay...

Siemens Healthineers 3gAllergy assay

Siemens Healthineers has expanded its 3gAllergy assay menu with nine additional component...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd